Evaluation of therapeutic action of <i>Pisum sativu</i> m in management of polycystic ovarian syndrome and formulating its sustained release tablet

Objectives: Polycystic ovarian syndrome (PCOS) is a multifactorial endocrine disorder marked by hormonal imbalance, anovulation, and polycystic ovarian morphology. Although clomiphene citrate is primarily prescribed for women with PCOS seeking fertility treatment, aligning with its established clinical indication for ovulation induction. This study aims to investigate the therapeutic potential of the methanolic extract of Pisum sativum seeds (MEPS) in a letrozole-induced PCOS rat model and to assess its bioactive composition and interaction with estrogen receptors. Materials and Methods: PCOS was experimentally induced using oral letrozole (1 mg/kg/day) for 21 days. Rats were subsequently treated with MEPS at doses of 200 and 400 mg/kg, and the standard group received clomiphene only for 15 days. Phytochemical constituents were identified via standard tests and thin-layer chromatography (TLC), and in silico docking assessed ligand binding to estrogen receptors. Antioxidant potential was evaluated using the 2,2-Diphenyl-1-Picrylhydrazyl assay. Biological assessments included hormonal assays (follicle-stimulating hormone, luteinizing hormone, estrogen, progesterone, and testosterone), insulin levels, hepatic enzyme activity, lipid profiling, body weight monitoring, estrous cycle analysis, and ovarian histopathology. Results: Phytochemical testing confirmed the presence of flavonoids and phenolics. TLC analysis indicated the presence of quercetin, catechin, and epicatechin. Docking studies demonstrated strong binding of these compounds with estrogen receptors. MEPS administration significantly improved hormonal balance, restored estrous cyclicity, reduced insulin and liver enzyme levels, and normalized ovarian architecture. The 400 mg/kg dose showed comparable outcomes to clomiphene citrate. Conclusion: MEPS effectively counteracted PCOS-related alterations in the rat model, likely through its phytoestrogenic and antioxidant mechanisms.

Authors

Institutions

Publication Details

Journal
American Journal of Pharmacotherapy and Pharmaceutical Sciences
Published
2026-03-02
DOI
https://doi.org/10.25259/ajpps_2026_008
Primary Topic
Phytochemistry and biological activities of Ficus species
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of therapeutic action of Pisum sativu m in management of polycystic ovarian syndrome and formulating its sustained release tablet

Tejas Ganatra, Aakash P. Chavda
American Journal of Pharmacotherapy and Pharmaceutical Sciences
Phytochemistry and biological activities of Ficus species
article

Evaluation of therapeutic action of Pisum sativu m in management of polycystic ovarian syndrome and formulating its sustained release tablet

Tejas Ganatra, Aakash P. Chavda
article en

Abstract

Objectives: Polycystic ovarian syndrome (PCOS) is a multifactorial endocrine disorder marked by hormonal imbalance, anovulation, and polycystic ovarian morphology. Although clomiphene citrate is primarily prescribed for women with PCOS seeking fertility treatment, aligning with its established clinical indication for ovulation induction. This study aims to investigate the therapeutic potential of the methanolic extract of Pisum sativum seeds (MEPS) in a letrozole-induced PCOS rat model and to assess its bioactive composition and interaction with estrogen receptors. Materials and Methods: PCOS was experimentally induced using oral letrozole (1 mg/kg/day) for 21 days. Rats were subsequently treated with MEPS at doses of 200 and 400 mg/kg, and the standard group received clomiphene only for 15 days. Phytochemical constituents were identified via standard tests and thin-layer chromatography (TLC), and in silico docking assessed ligand binding to estrogen receptors. Antioxidant potential was evaluated using the 2,2-Diphenyl-1-Picrylhydrazyl assay. Biological assessments included hormonal assays (follicle-stimulating hormone, luteinizing hormone, estrogen, progesterone, and testosterone), insulin levels, hepatic enzyme activity, lipid profiling, body weight monitoring, estrous cycle analysis, and ovarian histopathology. Results: Phytochemical testing confirmed the presence of flavonoids and phenolics. TLC analysis indicated the presence of quercetin, catechin, and epicatechin. Docking studies demonstrated strong binding of these compounds with estrogen receptors. MEPS administration significantly improved hormonal balance, restored estrous cyclicity, reduced insulin and liver enzyme levels, and normalized ovarian architecture. The 400 mg/kg dose showed comparable outcomes to clomiphene citrate. Conclusion: MEPS effectively counteracted PCOS-related alterations in the rat model, likely through its phytoestrogenic and antioxidant mechanisms.

American Journal of Pharmacotherapy and Pharmaceutical SciencesVol. 5
RK University (IN)
Good health and well-being
Openalex Percentile: Top 38%
Phytochemistry and biological activities of Ficus species
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.